Layered double hydroxide nanoparticles as an appealing nanoparticle in gene/plasmid and drug delivery system in C2C12 myoblast cells
Source abstract
Abstract
Gene and drug delivery systems need crucial update in the issue of nanocarriers. Layered double hydroxides (LDHs) are known as biocompatible inorganic lamellar nanomaterials with versatile properties. In the present study, Zn/Al-LDH nanoparticle was synthesized and characterized by FTIR, XRD, SEM, TEM and Zeta potential tests and then intercalated with valproate and methyldopa by co-precipitation and ion exchange methods. These nanocarriers were applied as high activity nanolayers-based delivery systems. On the other hand, Zn/Al-LDH + plasmid/gene (pCEP4/Cdk9) evaluated on C2C12 myoblast cells. Co-operation loading indicated high efficiency of sorting and release of drugs. Additionally, the Real-Time PCR and Western blotting results for plasmid-gene (pCEP4/Cdk9) delivery showed that Zn/Al-LDH nanoparticles can be used as an effective carrier in cellular uptake and release of genes for gene therapy. Easy and cost-effective production of Zn/Al-LDH nanoparticles proposed them as potential alternatives for the traditional routs of drug/gene delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Inorganic Chemistry and Materials · Nanomaterials for catalytic reactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences
Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences
Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences
Faculty of Pharmacy, Tabriz University of Medical Sciences
Department of Chemistry, Faculty of Science, University of Maragheh
References (32)
Show source-provided references
1. 10.1186/s13065-014-0047-210.1186/s13065-014-0047-2 ↗
2. 10.1016/j.clay.2013.12.00210.1016/j.clay.2013.12.002 ↗
3. 10.2147/IJN.S2156710.2147/IJN.S21567 ↗
4. 10.1016/j.clay.2009.11.03210.1016/j.clay.2009.11.032 ↗
5. 10.1016/j.jconrel.2003.12.02710.1016/j.jconrel.2003.12.027 ↗
6. 10.1016/j.clay.2015.04.01810.1016/j.clay.2015.04.018 ↗
7. 10.1016/j.clay.2004.07.00210.1016/j.clay.2004.07.002 ↗
8. 10.1016/j.biomaterials.2011.05.08310.1016/j.biomaterials.2011.05.083 ↗
9. 10.1016/j.biomaterials.2010.07.07710.1016/j.biomaterials.2010.07.077 ↗
10. 10.1021/ja056652a10.1021/ja056652a ↗
11. 10.2147/IJN.S2.2.16310.2147/IJN.S2.2.163 ↗
12. 10.1016/j.jconrel.2008.05.02110.1016/j.jconrel.2008.05.021 ↗
13. 10.1007/978-1-59745-218-2_1410.1007/978-1-59745-218-2_14 ↗
14. 10.2147/IJN.S2451010.2147/IJN.S24510 ↗
15. 10.1016/j.colsurfb.2009.05.00510.1016/j.colsurfb.2009.05.005 ↗
16. 10.3109/21691401.2014.97523710.3109/21691401.2014.975237 ↗
17. 10.1016/j.jconrel.2013.03.03410.1016/j.jconrel.2013.03.034 ↗
18. 10.1016/j.clay.2012.04.00410.1016/j.clay.2012.04.004 ↗
19. 10.1016/j.jcis.2012.09.03310.1016/j.jcis.2012.09.033 ↗
20. 10.1016/j.biomaterials.2003.09.08310.1016/j.biomaterials.2003.09.083 ↗
21. 10.1021/cm060512y10.1021/cm060512y ↗
22. 10.1016/j.biomaterials.2009.10.05810.1016/j.biomaterials.2009.10.058 ↗
23. 10.1016/j.solidstatesciences.2008.01.02610.1016/j.solidstatesciences.2008.01.026 ↗
24. 10.1002/jcb.2621310.1002/jcb.26213 ↗
25. 10.1016/j.jpowsour.2017.10.03710.1016/j.jpowsour.2017.10.037 ↗
26. 10.1016/j.jcis.2015.07.07310.1016/j.jcis.2015.07.073 ↗
27. 10.1016/j.jtusci.2015.10.00710.1016/j.jtusci.2015.10.007 ↗
28. 10.1016/j.imlet.2017.08.02810.1016/j.imlet.2017.08.028 ↗
29. 10.1021/la000872e10.1021/la000872e ↗
30. 10.1016/j.apsusc.2006.05.02310.1016/j.apsusc.2006.05.023 ↗
31. 10.1016/S0040-6090(97)00438-010.1016/S0040-6090(97)00438-0 ↗
32. Eyvazi S, Hejazi M, Kahroba H, et al. Cdk9 as an appealing target for therapeutic interventions. Curr Drug Targets. 2018;in-press.